Advancing Generative AI in Healthcare
Yale Joins Global AI Precision Medicine Initiative
A 21-member consortium secures €16.9 million to develop mechanistic AI models for personalized disease treatment.
A digital visualization of a DNA helix appearing on a laboratory tablet, representing the use of AI in precision medicine research.
Photo: Avantgarde News
Yale School of Medicine researchers have joined a 21-member international consortium to launch the AIRIS project [1]. This initiative aims to develop generative AI models that move beyond simple statistical patterns to model actual disease progression [1]. The European Union's Horizon Europe Programme awarded the project a €16.9 million grant to advance the field of personalized medicine [1][2].
The AIRIS project focuses on creating mechanistic models that simulate biological processes instead of just identifying correlations [1]. These sophisticated tools will allow clinicians to predict how individual patients might respond to specific treatments [2]. By modeling the biological mechanisms of disease, the team seeks to provide more accurate health outcomes than current black-box AI methods [1][2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The risk level is set to high because the story relies on only two independent source domains, which is below the recommended threshold of three.
Sources
Related stories
View allTopics
About the author
Avantgarde News Desk covers advancing generative ai in healthcare and editorial analysis for Avantgarde News.
